Evogene Ltd. logo

Evogene Ltd.

NASDAQ:EVGN

Overview | Financials
Company Name Evogene Ltd.
Symbol EVGN
Currency USD
Price 0.725
Market Cap 36,674,045
Dividend Yield 0%
52-week-range 0.45 - 1.44
Industry Biotechnology
Sector Healthcare
CEO Mr. Ofer Haviv CPA
Website https://www.evogene.com

An error occurred while fetching data.

About Evogene Ltd.

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through

Related Stocks

Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc.

MBRX

4.96 USD

Applied Therapeutics, Inc. logo

Applied Therapeutics, Inc.

APLT

4.24 USD

AVROBIO, Inc. logo

AVROBIO, Inc.

AVRO

1.38 USD

Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc.

COCP

1.9 USD

Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc.

TPST

3.36 USD

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

TERN

6.12 USD

Financials

Numbers are in millions USD

Numbers are in millions USD